You are here

Kymera

Kymera’s protein degrader starts Phase II trial in atopic dermatitis

Clinical Trials Arena

Fri, 12/8/23 - 11:05 am

protein degradation

clinical trials

atopic dermatitis

Kymera’s pain could be Priovant’s gain

EP Vantage

Tue, 08/30/22 - 11:41 am

hidradenitis suppurativa

Key data catalysts for the industry’s small players

EP Vantage

Fri, 07/1/22 - 09:35 am

Intercept Pharma

atopic dermatitis

short bowel syndrome

Assembly Biosciences

Kymera, raising $173M+, becomes the 48th biotech IPO of the year as 2020 surpasses 2019

Endpoints

Fri, 08/21/20 - 12:06 pm

Out to revive R&D, a resurgent Sanofi pays $150M cash to partner up with a pioneering protein degradation player

Endpoints

Thu, 07/9/20 - 10:57 am

protein degradation

Big Pharma Bets on Body’s Garbage-Disposal System to Beat Cancer

Bloomberg

Thu, 10/10/19 - 07:55 pm

targeted protein degradation

Drugging The Undruggable: Kymera's Targeted Protein Degradation

Forbes

Mon, 10/30/17 - 10:01 am

targeted protein degradation

drug development